{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:45:13Z","timestamp":1789616713192,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ejpb.2018.10.011","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T07:39:53Z","timestamp":1539675593000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["In situ co-amorphisation of arginine with indomethacin or furosemide during immersion in an acidic medium \u2013 A proof of concept study"],"prefix":"10.1016","volume":"133","author":[{"given":"Ina","family":"Petry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korbinian","family":"L\u00f6bmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Grohganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia S.","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.10.011_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425247.4.4.403","article-title":"Drug delivery strategies for poorly water-soluble drugs","volume":"4","author":"Fahr","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.10.011_b0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2015.12.009","article-title":"Recent advances in co-amorphous drug formulations","volume":"100","author":"Dengale","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.10.011_b0020","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/js980403l","article-title":"Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs","volume":"88","author":"Serajuddin","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.10.011_b0025","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ejpb.2013.09.010","article-title":"In situ amorphisation of indomethacin with Eudragit\u00ae E during dissolution","volume":"85","author":"Priemel","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jddst.2016.02.003","article-title":"Glass solution formation in water - In situ amorphization of naproxen and ibuprofen with Eudragit\u00ae E PO","volume":"34","author":"Doreth","year":"2016","journal-title":"J. Drug Del. Sci. Tech."},{"key":"10.1016\/j.ejpb.2018.10.011_b0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpb.2017.10.001","article-title":"Influence of PVP molecular weight on the microwave assisted in situ amorphization of indomethacin","volume":"122","author":"Doreth","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jphp.12494","article-title":"Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling","volume":"68","author":"Lim","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.10.011_b0045","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/mp2002973","article-title":"Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen","volume":"8","author":"L\u00f6bmann","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12247-013-9162-1","article-title":"Drug\u2013drug coamorphous systems: characterization and physicochemical properties of coamorphous atorvastatin with carvedilol and glibenclamide","volume":"8","author":"Shayanfar","year":"2013","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ejpb.2018.10.011_b0055","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ejpb.2013.03.014","article-title":"Amino acids as co-amorphous stabilizers for poorly water soluble drugs-Part 1: preparation, stability and dissolution enhancement","volume":"85","author":"L\u00f6bmann","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0060","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1021\/mp500107s","article-title":"Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability","volume":"11","author":"Laitinen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0065","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/acs.molpharmaceut.5b00295","article-title":"Formation mechanism of coamorphous drug-amino acid mixtures","volume":"12","author":"Jensen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejps.2016.08.022","article-title":"Development of a screening method for co-amorphous formulations of drugs and amino acids","volume":"95","author":"Kasten","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.10.011_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1515\/acph-2015-0014","article-title":"Clozapine-carboxylic acid plasticized co-amorphous dispersions: preparation, characterization and solution stability evaluation","volume":"65","author":"Ali","year":"2015","journal-title":"Acta Pharmaceutica"},{"key":"10.1016\/j.ejpb.2018.10.011_b0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijpharm.2016.10.043","article-title":"Co amorphous systems: a product development perspective","volume":"515","author":"Chavan","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejpb.2015.07.011","article-title":"Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine","volume":"96","author":"Lenz","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejpb.2017.06.007","article-title":"Solid state properties and drug release behavior of co-amorphous indomethacin-arginine tablets coated with Kollicoat\u00ae Protect","volume":"119","author":"Petry","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2016.06.020","article-title":"Influence of variation in molar ratio on co-amorphous drug-amino acid systems","volume":"107","author":"Jensen","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0100","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/BF00547442","article-title":"Tensile fracture of doubly-convex cylindrical discs under diametral loading","volume":"23","author":"Pitt","year":"1988","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.ejpb.2018.10.011_b0105","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/jps.2600720928","article-title":"Kinetics and mechanism of the basic hydrolysis of indomethacin and related compounds: A reevaluation","volume":"72","author":"Cipiciani","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.10.011_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/207028","article-title":"Validated reverse-phase high-performance liquid chromatography for quantification of furosemide in tablets and nanoparticles","volume":"2013","author":"Youm","year":"2013","journal-title":"J. Anal. Methods Chem."},{"key":"10.1016\/j.ejpb.2018.10.011_b0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0040-6031(02)00212-5","article-title":"New heat flux DSC measurement technique","volume":"395","author":"Danley","year":"2003","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejpb.2018.10.011_b0120","unstructured":"http:\/\/www.drugs.com\/dosage\/indomethacin, Indomethacin dosage (2018)."},{"key":"10.1016\/j.ejpb.2018.10.011_b0125","unstructured":"http:\/\/www.drugs.com\/dosage\/furosemide, Furosemide dosage (2018)."},{"key":"10.1016\/j.ejpb.2018.10.011_b0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2018.04.026","article-title":"Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions","volume":"544","author":"Petry","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0135","unstructured":"EUDRAGIT\u00ae Application Guidelines, 12 ed., Evonik Industries, Darmstadt, Germany."},{"key":"10.1016\/j.ejpb.2018.10.011_b0140","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2010"},{"key":"10.1016\/j.ejpb.2018.10.011_b0145","series-title":"Polymers for controlled drug delivery","author":"Agyilirah","year":"1991"},{"key":"10.1016\/j.ejpb.2018.10.011_b0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijpharm.2012.03.011","article-title":"Yellow coloration phenomena of incorporated indomethacin into folded sheet mesoporous materials","volume":"429","author":"Tanabe","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0155","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/03639040802516491","article-title":"The characterization and comparison of spray-dried mannitol samples","volume":"35","author":"Hulse","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO;2-G","article-title":"Energy\/Temperature diagram and compression behavior of the polymorphs of d-mannitol","volume":"89","author":"Burger","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.10.011_b0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2017.10.057","article-title":"On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems","volume":"535","author":"Wu","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.10.011_b0170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jphp.12458","article-title":"Preparation and characterization of spray-dried co-amorphous drug-amino acid salts","volume":"68","author":"Jensen","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.10.011_b0175","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.xphs.2016.09.027","article-title":"Hot melt extrusion and spray drying of co-amorphous indomethacin-arginine with polymers","volume":"106","author":"Lenz","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.10.011_b0180","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejpb.2013.03.026","article-title":"Amino acids as co-amorphous stabilizers for poorly water-soluble drugs-Part 2: molecular interactions","volume":"85","author":"L\u00f6bmann","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111830746X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111830746X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T08:08:01Z","timestamp":1542442081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964111830746X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"alternative-id":["S093964111830746X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.10.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ co-amorphisation of arginine with indomethacin or furosemide during immersion in an acidic medium \u2013 A proof of concept study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}